Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Other Non-Current Liabilities (2018 - 2025)

Dna X (SONM) has disclosed Other Non-Current Liabilities for 8 consecutive years, with $1.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities rose 12.39% year-over-year to $1.8 million, compared with a TTM value of $1.8 million through Sep 2025, up 12.39%, and an annual FY2024 reading of $1.7 million, up 11.19% over the prior year.
  • Other Non-Current Liabilities was $1.8 million for Q3 2025 at Dna X, up from $1.8 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.8 million in Q3 2025 and bottomed at $1.3 million in Q1 2021.
  • Average Other Non-Current Liabilities over 5 years is $1.5 million, with a median of $1.5 million recorded in 2023.
  • The sharpest move saw Other Non-Current Liabilities crashed 40.7% in 2021, then rose 16.12% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $1.4 million in 2021, then increased by 1.42% to $1.4 million in 2022, then rose by 6.93% to $1.5 million in 2023, then increased by 11.19% to $1.7 million in 2024, then increased by 6.77% to $1.8 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for SONM at $1.8 million in Q3 2025, $1.8 million in Q2 2025, and $1.8 million in Q1 2025.